EKB Journal Management System
Volume & Issue: Volume 6, Issue 2, June 2022, Page 1-77  XML

1

Gene-behavior theory: Behavior from nil to tangible glycosylation-implications for cancer prognosis and treatment strategies

Page 1-6
Seif Mohamed

2

Indomethacin Suppresses Cisplatin-Resistant Murine Breast Cancer Through Modulating MicroRNAs Expression and Stimulating Antitumor Immunity

Page 7-21
Nageh Ahmed Elmahdy; Norhan Mobark; Magda Elsayad; Mohamed Labib Salem

3

Ethylenediamine tetra acetic acid (EDTA) enhances the antitumor efficacy of cisplatin against human breast cancer cells in vitro

Page 23-29
Sabry A. El-Naggar; Yousry El-Bolkiny; Fatheya Makboul Ibrahim

4

Predicting causes of death among vulvar cancer patients; SEER database analysis

Page 31-40
Mohamed Tarek Hafez; Gehad Tawfik; Reem Yousef; Sarah Antar Antar; Ahmed Nazzal; Mona Hosh; Mahmoud Warda; Richard Leu; Basel Refky

5

Significance of CD200 expression in patients with acute myeloid leukemia and its correlation with other prognostic markers

Page 41-54
Ahmed Magdy Rabea; Hala Farawela; Rania Soliman; Naglaa Hassan; Reem Nabil; Mohamed Fouad

6

RRBP1 Expression in wild and mutated p53 immunophenotype endometrioid endometrial carcinoma: Relation to ER-α and clinicopathologic factors

Page 55-66
Marwa Ali; Shaimaa Bebars

7

The validity of giving adjuvant capecitabine after standard anthracycline and/or taxanes based neo-/adjuvant chemotherapy in early triple-negative breast cancer patients: An Egyptian prospective multicentric phase III trial

Page 67-77
lobna A. Abdelaziz; Ahmed mubarak Hefni; Alia M. Attia; loay Gertalla; Marwa Abdelgawad